FDA Scientists Take Recombinant Step Toward Faster Development Of Flu Vaccines
Executive Summary
Scientists at FDA have taken a step toward speeding the approval of influenza vaccines: They have demonstrated a faster way to produce the reagent used to evaluate a vaccine's potency.